ELV截止日期：Rosen Law Firm敦促损失超过10万美元的Elevance Health, Inc. 股东与律所联系以了解有关其权利的信息

美国商业资讯2025-06-29

(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2024年4月18日至2024年10月16日期间购买Elevance Health, Inc. （NYSE: ELV）普通股的投资者提起集体诉讼。Elevance自称是"一家为多元市场提供健康保险计划的医疗保健企业"。如需了解更多信息，请提交表格、向Phillip Kim律师发送电子邮件，或...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2547608713?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-29 18:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2547608713","market":"us","top_or_hot":-1,"title":"ELV截止日期：Rosen Law Firm敦促损失超过10万美元的Elevance Health, Inc. 股东与律所联系以了解有关其权利的信息","media":"美国商业资讯","content":"<div>\n<p>(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2024年4月18日至2024年10月16日期间购买Elevance Health, Inc. （NYSE: ELV）普通股的投资者提起集体诉讼。Elevance自称是\"一家为多元市场提供健康保险计划的医疗保健企业\"。如需了解更多信息，请提交 表格 、向Phillip Kim律师发送 电子邮件 ，或...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630023113a72462a3&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ELV截止日期：Rosen Law Firm敦促损失超过10万美元的Elevance Health, Inc. 股东与律所联系以了解有关其权利的信息</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nELV截止日期：Rosen Law Firm敦促损失超过10万美元的Elevance Health, Inc. 股东与律所联系以了解有关其权利的信息\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-29 18:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630023113a72462a3&s=b><strong>美国商业资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2024年4月18日至2024年10月16日期间购买Elevance Health, Inc. （NYSE: ELV）普通股的投资者提起集体诉讼。Elevance自称是\"一家为多元市场提供健康保险计划的医疗保健企业\"。如需了解更多信息，请提交 表格 、向Phillip Kim律师发送 电子邮件 ，或...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630023113a72462a3&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4154","symbol_name":"管理型保健护理","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630023113a72462a3&s=b","article_id":"2547608713","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630023113a72462a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2547608713","pubTimestamp":1751193000,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2024年4月18日至2024年10月16日期间购买Elevance Health, Inc. 普通股的投资者提起集体诉讼。关于Rosen Law Firm：与Rosen Law Firm不同，一些就此等事宜发布公告的律师事务所并不会实际提起证券集体诉讼。自成立以来，Rosen Law Firm已经为股东挽回了超过10亿美元的损失。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4154":"管理型保健护理","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1548497426.USD":"安联环球人工智能AT Acc","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","ELV":"Elevance Health","LU0122379950.USD":"贝莱德世界健康科学A2","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","BK4585":"ETF&股票定投概念","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0251142724.SGD":"Fidelity America A-SGD","SG9999001077.SGD":"United International Growth Fund SGD","LU1670628061.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) INC","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0557290698.USD":"施罗德环球可持续增长基金","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC"},"translate_title":"ELV deadline: Rosen Law Firm urges Elevance Health, Inc. shareholders who lost more than $100,000 to contact law firms for information on their rights","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表在2024年4月18日至2024年10月16日期间购买Elevance Health, Inc. （NYSE: ELV）普通股的投资者提起集体诉讼。Elevance自称是\"一家为多元市场提供健康保险计划的医疗保健企业\"。如需了解更多信息，请提交 表格 、向Phillip Kim律师发送 电子邮件 ，或致电866-767-3653联系我们。指控内容：Rosen Law Firm正在调查针对Elevance Health, Inc. （NYSE: ELV）涉嫌在其业务运营方面误导投资者的相关指控。起诉书指称，在整个集体诉讼期内，被告作出了虚假和误导性陈述，且未披露以下事实：在医疗补助计划（Medicaid）资格重审程序接近完成之际，被告向投资者声称其正密切监控重审流程相关的成本趋势，并宣称Elevance与各州协商的保费费率足以覆盖继续参与医疗补助计划患者的风险及成本状况。尽管被告承认医疗补助支出正在上升，但多次向投资者保证该情况已充分体现在公司年度财务指引中。这些陈述存在重大虚假或误导性。事实上，资格重审程序正导致Elevance医疗补助参保成员的医疗需求强度及服务使用率显著上升，这是因为被移出医疗补助计划的成员通常比保留资格者更为健康。这一变化的影响程度，既未体现在Elevance与各州进行的费率协商中，也未反映在其2024年财务指引里。。诉讼称，当市场了解真实详情后，投资者蒙受了损失。现在怎么办：您可能有资格参与针对Elevance Health, Inc.的集体诉讼。如果有股东希望担任该集体诉讼的首席原告，则必须在2025年7月11日之前向法院提出申请。首席原告是指代表其他集体诉讼成员主导诉讼的当事人代表。您无需参与此案即有资格获得追偿。如果您选择不采取任何行动，您也可以保持缺席集体诉讼成员的身份。如需了解更多信息，请点击 此处 。所有代理均为胜诉后取酬。股东无需支付任何费用或开支。关于Rosen Law Firm：与Rosen Law Firm不同，一些就此等事宜发布公告的律师事务所并不会实际提起证券集体诉讼。作为股东权益诉讼领域公认的领导者， Rosen Law Firm 一直致力于帮助股东挽回损失、改善公司治理结构，并追究公司高管的违法行为责任。自成立以来，Rosen Law Firm已经为股东挽回了超过10亿美元的损失。请在LinkedIn： https://www.linkedin.com/company/the-rosen-law-firm 、Twitter： https://twitter.com/rosen_firm 或Facebook： https://www.facebook.com/rosenlawfirm/ 上关注我们，以了解最新情况。律师广告。先前案例不保证可实现类似结果。免责声明：本公告之原文版本乃官方授权版本。译文仅供方便了解之用，烦请参照原文，原文版本乃唯一具法律效力之版本。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2547608713","isCrawlerRequest":true}